Bank Of America Corp Gossamer Bio, Inc. Transaction History
Bank Of America Corp
- $1.12 Trillion
- Q2 2024
A detailed history of Bank Of America Corp transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 42,287 shares of GOSS stock, worth $37,635. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,287
Previous 119,966
64.75%
Holding current value
$37,635
Previous $141,000
73.05%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding GOSS
# of Institutions
103Shares Held
176MCall Options Held
453KPut Options Held
543K-
Nea Management Company, LLC Timonium, MD18.1MShares$16.1 Million1.54% of portfolio
-
Artal Group S.A. Luxembourg, N413.3MShares$11.8 Million0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$10.5 Million0.0% of portfolio
-
Octagon Capital Advisors LP New York, NY9.19MShares$8.18 Million1.91% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$7.17 Million4.25% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $83.6M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...